G-csf conjugates

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/53 (2006.01)

Patent

CA 2452582

Polypeptide conjugates with G-CSF activity comprising a polypeptide having at least one introduced lysine residue and at least one removed lysine residue compared to the sequence of human G-CSF, and which are conjugated to 2-6 polyethylene glycol moieties. The conjugates have a lowin vitro bioactivity, a long in vivo half-life, a reduced receptor-mediated clearance, and provide a more rapid stimulation of production of white blood cells and neutrophils than non-conjugates recombinant human G-CSF.

Conjugués de polypeptides manifestant une activité de G-CSF comprenant un polypeptide possédant au moins un résidu de lysine introduit et au moins un résidu de lysine retiré en comparaison à la séquence de G-CSF humain, qui sont conjugués avec 2 à 6 groupes fonctionnels de polyéthylène glycol. Ces conjugués manifestent une faible bio-activité in vitro, une longue demi-vie in vivo, une plus faible clairance à médiation par le récepteur et assurent une stimulation plus rapide de la production de leucocytes et de neutrophiles que les G-CSF humains non recombinants.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

G-csf conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with G-csf conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and G-csf conjugates will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1727799

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.